Literature DB >> 16359749

A similarity measure for case based reasoning modeling with temporal abstraction based on cross-correlation.

Florian Hartge1, Thomas Wetter, Walter E Haefeli.   

Abstract

Adverse drug events (ADEs) are a major limitation of drug safety. They are often caused by inappropriate selection of dose and the concurrent use of drugs modulating each other (drug interaction). Risk assessment and prevention strategies must therefore consider co-administered drugs, individual doses, and their timing. In a new approach we evaluated the performance of cross correlation, commonly used in signal processing, to determine similarities in patient treatments. To achieve this, patient treatments were modeled as groups of vectors representing discrete time intervals. These vectors were cross-correlated and the results evaluated to find clusters in time courses indicating similarity in treatment of different patients. To evaluate our algorithm, we then created a number of test cases. The focus of this article is on each treatment, and its pattern in time and dosage. The algorithm successfully produces a relatively low similarity score for cases that are completely different with respect to their pattern of time and dosage but high scores when they are equal (score of 0.699) or similar (score of 0.528) in their therapies, and thus succeeds in having a relatively high specificity (27/30). Such an approach might help to considerably reduce the problem of false alarms which hampers most existing alerting systems for medication errors or impending ADEs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359749     DOI: 10.1016/j.cmpb.2005.10.005

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  2 in total

1.  Patient Similarity: Emerging Concepts in Systems and Precision Medicine.

Authors:  Sherry-Ann Brown
Journal:  Front Physiol       Date:  2016-11-24       Impact factor: 4.566

2.  Methods for a similarity measure for clinical attributes based on survival data analysis.

Authors:  Christian Karmen; Matthias Gietzelt; Petra Knaup-Gregori; Matthias Ganzinger
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-21       Impact factor: 2.796

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.